**Core Concept:** Infections with hepatitis B virus (HBV) lead to the production of specific viral markers that help diagnose the infection and monitor its progression. These markers include: HBsAg (hepatitis B surface antigen), anti-HBs (antibody to HBsAg), HBeAg (hepatitis B e antigen), and anti-HBe (antibody to HBeAg).

**Why the Correct Answer is Right:** HBsAg is the first viral marker to appear in the blood during acute hepatitis B infection. It indicates the presence of active viral replication and represents the virus itself or viral proteins. Detecting HBsAg is crucial for diagnosing acute hepatitis B, as well as chronic hepatitis B patients who are highly infectious due to the presence of active viral replication.

**Why Each Wrong Option is Incorrect:**

A. Anti-HBs: This is a marker of immunity, developed in response to past infection or التطعيمات. It does not appear until weeks to months after infection and is not the first marker detected.

B. Anti-HBe: This marker indicates the presence of immunity against hepatitis B, rather than the acute infection itself. It is detected after the appearance of HBeAg and appears later in the course of the infection.

C. Anti-HBc (antibody to hepatitis B core antigen): This marker is a marker of past infection and immunity, appearing weeks to months after the acute infection. It is not the first marker detected.

D. HBeAg: This marker indicates the presence of active viral replication and is detected after the appearance of HBsAg. It appears later in the course of the infection.

**Clinical Pearl:** Monitoring viral marker changes, particularly the sequential appearance of HBsAg, HBeAg, and anti-HBe, helps in understanding the progression of hepatitis B infection and response to treatment. This pattern is crucial for the diagnosis and management of hepatitis B patients, ensuring appropriate timing for initiating antiviral therapy and assessing treatment response.

**Correct Answer:** D. HBeAg is the correct answer because it represents the presence of active viral replication and is detected after the appearance of HBsAg. This sequential detection of viral markers helps in understanding the progression of hepatitis B infection and response to treatment. The correct sequence is:

1. HBsAg is detected early, indicating acute infection.
2. HBeAg is detected later, indicating active viral replication.
3. Anti-HBe is detected later, indicating a transition from active viral replication to inactive carrier state or resolution of infection.

4. Anti-HBs is detected as immunity develops, usually later than HBeAg and anti-HBe.

The sequential detection of these markers guides clinicians in managing patients with hepatitis B infection, ensuring appropriate timing for antiviral therapy initiation and assessing treatment response.